Multivalent Antibiotics via Metal Complexes: Potent Divalent Vancomycins against Vancomycin-Resistant Enterococci

Journal of Medicinal Chemistry

Volumn 46, Issue 23, 2003, Pages 4904-4909

  Xing, Bengang ^a   Yu, Chun Wing ^a   Ho, Pak Leung ^b   Chow, Kin Hung ^b   Cheung, Terence ^b   Gu, Hongwei ^a   Cai, Zongwei ^c   Xu, Bing ^a  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN DERIVATIVE; DIMER; DRUG RECEPTOR; LIGAND; METAL COMPLEX; VANCOMYCIN DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; COMPLEX FORMATION; DRUG POTENCY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; ENTEROCOCCUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROTEIN INTERACTION;

EID: 0242331083     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm030417q     Document Type: Article

References (49)

1. Neu, H. C. The Crisis in Antibiotic-Resistance. Science 1992, 257, 1064-1073.
2. Breukink, E.; Wiedemann, I.; van Kraaij, C.; Kuipers, O. P.; Sahl, H. G. et al. Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic. Science 1999, 286, 2361-2364.
3. Chiosis, G.; Boneca, I. G. Selective Celavage of D-Ala-D-Lac by Small Molecules: Re-Sensitizing Resistant Bacteria to Vancomycin. Science 2001, 293, 1484-1487.
4. Ge, M.; Chen, Z.; Onishi, H. R.; Kohler, J.; Silver, L. L. et al. Vancomycin derivatives that inhibit peptidoglycan biosynthesis without binding D-Ala-D-Ala. Science 1999, 284, 507-511.
5. Kohli, R. M.; Walsh, C. T.; Burkart, M. D. Biomimetic synthesis and optimization of cyclic peptide antibiotics. Nature 2002, 418, 658-661.
6. Trauger, J. W.; Kohli, R. M.; Mootz, H. D.; Marahiel, M. A.; Walsh, C. T. Peptide cyclization catalysed by the thioesterase domain of tyrocidine synthetase. Nature 2000, 407, 215-218.
7. Koeller, K. M.; Wong, C. H. Emerging themes in medicinal glycoscience. Nat. Biotech. 2000, 18, 835-841.
8. Liu, H. T.; Sadamoto, R.; Sears, P. S.; Wong, C. H. An efficient chemoenzymatic strategy for the synthesis of wild-type and vancomycin-resistant bacterial cell-wall precursors: UDP-N-acetylmuramyl-peptides. J. Am. Chem. Soc. 2001, 123, 9916-9917.
9. Mammen, M.; Choi, S. K.; Whitesides, G. M. Polyvalent interactions in biological systems: Implications for design and use of multivalent ligands and inhibitors. Angew. Chem., Int. Ed. 1998, 37, 2755-2794.
10. Cooper, M. A.; Williams, D. H. Binding of glycopeptide antibiotics to a model of a vancomycin-resistant bacterium. Chem. Biol. 1999, 6, 891-899.
11. Rao, J. H.; Lahiri, J.; Isaacs, L.; Weis, R. M.; Whitesides, G. M. A trivalent system from vancomycin center dot D-Ala-D-Ala with higher affinity than avidin center dot biotin. Science 1998, 280, 708-711.
12. Rao, J.; Yan, L.; Xu, B.; Whitesides, G. M. Using surface plasmon resonance to study the binding of vancomycin and its dimer to self-assembled monolayers presenting D-Ala-D-Ala. J. Am. Chem. Soc. 1999, 121, 2629-2630.
13. Rao, J. H.; Lahiri, J.; Weis, R. M.; Whitesides, G. M. Design, synthesis, and characterization of a high-affinity trivalent system derived from vancomycin and L-Lys-D-Ala-D-Ala. J. Am. Chem. Soc. 2000, 122, 2698-2710.
14. Rao, J. H.; Yan, L.; Lahiri, J.; Whitesides, G. M.; Weis, R. M. et al. Binding of a dimeric derivative of vancomycin to L-Lys-D-Ala-D-Lact in solution and at a surface. Chem. Biol. 1999, 6, 353-359.
15. Nicolaou, K. C.; Hughes, R.; Cho, S. Y.; Winssinger, N.; Labischinski, H. et al. Synthesis and biological evaluation of vancomycin dimers with potent activity against vancomycin-resistant bacteria: target- accelerated combinatorial synthesis. Chem. Eur. J. 2001, 7, 3824-3843.
16. Nicolaou, K. C.; Hughes, R.; Cho, S. Y.; Winssinger, N.; Smethurst, C. et al. Target-accelerated combinatorial synthesis and discovery of highly potent antibiotics effective against vancomycin-resistant bacteria. Angew. Chem., Int. Ed. 2000, 39, 3823-3828.
17. Sundram, U. N.; Griffin, J. H.; Nicas, T. I. Novel vancomycin dimers with activity against vancomycin-resistant enterococci. J. Am. Chem. Soc. 1996, 118, 13107-13108.
18. Thoma, G.; Katopodis, A. G.; Voelcker, N.; Duthaler, R. O.; Streiff, M. B. Novel glycodendrimers self-assemble to nanoparticles which function as polyvalent ligands in vitro and in vivo. Angew. Chem., Int. Ed. 2002, 41, 3195-3198.
19. Nicolaou, K. C.; Mitchell, H. J.; Jain, N. F.; Winssinger, N.; Hughes, R. et al. Total synthesis of vancomycin. Angew. Chem., Int. Ed. 1999, 38, 240-244.
20. Nicolaou, K. C.; Boddy, C. N. C.; Brase, S.; Winssinger, N. Chemistry, biology, and medicine of the glycopeptide antibiotics. Angew. Chem., Int. Ed, 1999, 38, 2097-2152.
21. Hubbard, B. K.; Walsh, C. T. Vancomycin assembly: Nature's way. Angew. Chem., Int. Ed. 2003, 42, 730-765.
22. Evans, D. A.; Wood, M. R.; Trotter, B. W.; Richardson, T. I.; Barrow, J. C. et al. Total syntheses of vancomycin and eremomycin aglycons. Angew. Chem., Int. Ed. 1998, 37, 2700.
23. Novak, R.; Henriques, B.; Charpentier, E.; Normark, S.; Tuomanen, E. Emergence of vancomycin tolerance in Streptococcus pneumoniae. Nature 1999, 399, 590-593.
24. Walsh, C. Molecular mechanisms that confer antibacterial drug resistance. Nature 2000, 406, 775-781.
25. Walsh, C. T. Vancomycin Resistance - Decoding the Molecular Logic (Vol 261, Pg 469, 1993). Science 1993, 262, 164-164.
26. Walsh, C. Microbiology - Deconstructing vancomycin. Science 1999, 284, 442-443.
27. Walsh, C. Antibiotics: Actions, Origins, Resistance, 1st ed.; ASM press: Washington, D. C., 2003.
28. Popieniek, P. H.; Pratt, R. F. Anal. Biochem. 1987, 165, 108-113.
29. Waltho, J. P.; William, D. H. J. Am. Chem. Soc. 1989, 111, 2475-2480.
30. Williams, D. H.; Maguire, A. J.; Tsuzuki, W.; Westwell, M. S. An analysis of the origins of a cooperative binding energy of dimerization. Science 1998, 280, 711-714.
31. Shiozawa, H.; Chia, B. C. S.; Davies, N. L.; Zerella, R.; Williams, D. H. Cooperative binding interactions of glycopeptide antibiotics. J. Am. Chem. Soc. 2002, 124, 3914-3919.
32. Williams, D. H.; Cox, J. P. L.; Doig, A. J.; Gardner, M.; Gerhard, U. et al. Toward the Semiquantitative Estimation of Binding Constants - Guides for Peptide Peptide Binding in Aqueous-Solution. J. Am. Chem. Soc. 1991, 113, 7020-7030.
33. Williams, D. H.; Bardsley, B. The vancomycin group of antibiotics and the fight against resistant bacteria. Angew. Chem., Int. Ed. 1999, 38, 1173-1193.
34. Griffin, J. H.; Linsell, M. S.; Nodwell, M. B.; Chen, Q.; Pace, J. L. et al. Multivalen Drug Design. Synthesis and In Vitro Analysis of an Array of Vancomycin Dimers. J. Am. Chem. Soc. 2003, 125, 6517-6531.
35. Stack, D. R.; Thompson, R. G. EP 0801075 Al, 1997.
36. Mammen, M.; Shakhnovich, E. I.; Whitesides, G. M. Using a convenient, quantitative model for torsional entropy to establish qualitative trends for molecular processes that restrict conformational freedom. J. Org. Chem. 1998, 63, 3168-3175.
37. Searle, M. S.; Williams, D. H. The cost of conformational order: entropy changes in Molecular associations. J. Am. Chem. Soc. 1992, 114, 10690-10697.
38. Rosenberg, B.; VanCamp, L.; Trosko, J. E.; Mansour, V. H. Nature 1969, 222, 385-386.
39. Sakai, S.; Sasaki, T. Multivalent Carbohydrate Ligands Assembled on a Metal Template. J. Am. Chem. Soc. 1994, 116, 1587-1588.
40. Cuenoud, B.; Schepartz, A. Design of a Metallo Bzip-Protein That Discriminates between Cre and Ap1 Target Sites - Selection against Ap1. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 1154-1159.
41. Cuenoud, B.; Schepartz, A. Altered Specificity of DNA-Binding Proteins with Transition- Metal Dimerization Domains. Science 1993, 259, 510-513.
42. Mack, D. P.; Dervan, P. B. Sequence-Specific Oxidative Cleavage of DNA by a Designed Metalloprotein, Ni(Ii).Ggh(Hin139-190). Biochemistry 1992, 31, 9399-9405.
43. Dong, S. D.; Oberthur, M.; Losey, H. C.; Anderson, J. W.; Eggert, U. S. et al. The structural basis for induction of VanB resistance. J. Am. Chem. Soc. 2002, 124, 9064-9065.
44. Xing, B.; Yu, C.-W.; Chow, K.-H.; Ho, P.-L.; Fu, D. et al. Hydrophobic Interaction and Hydrogen Bonding Cooperatively Confer a Vancomycin Hydrogel: A Potential Candidate for Biomaterials. J. Am. Chem. Soc. 2002, 124, 14846-14847.
45. Gu, H.; Ho, P. L.; Tong, E.; Xu, C.; Xu, B. Presenting Vancomycin on Nanoparticles to Enhance Antimicrobial Activities. Nano Lett. 2003, 3, 1261-1263.
46. Xing, B.; Ho, P. L.; Yu, C.-W.; Chow, K.-H.; Gu, H. et al. Self-Assembled Multivalent Vancomycin on Cell Surfaces Against Vancomycin-Resistant Enterococci (VRE). Chem. Commun. 2003, 2224-2225.
47. Chen, Z.; Eggert, U. S.; Dong, S. D.; Shaw, S. J.; Sun, B. Y. et al. Structural requirements for VanA activity of vancomycin analogues. Tetrahedron 2002, 58, 6585-6594.
48. Kim, S. J.; Cegelski, L.; Studelska, D. R.; O'Connor, R. D.; Mehta, A. K. et al. Rotational-echo double resonance characterization of vancomycin binding sites in Staphylococcus aureus. Biochemistry 2002, 41, 6967-6977.
49. Cegelski, L.; Kim, S. J.; Hing, A. W.; Studelska, D. R.; O'Connor, R. D. et al. Rotational-echo double resonance characterization of the effects of vancomycin on cell wall synthesis in Staphylococcus aureus. Biochemistry 2002, 41, 13053-13058.